From Name:
From Email:
To Name:
To Email:

Optional Message:


Should the FDA force drug makers to discuss their clinical trials?

from Forbes

When developing a new drug, biopharmaceutical companies design clinical trials which, if successful, will garner approval from the FDA and other regulatory agencies around the world. Late stage clinical trials are time consuming and costly, with expenses running into tens, even hundreds, of millions of dollars. Oftentimes, you get only one chance to run such a program and so it's important to get the design right. Thus, it behooves companies to meet with the FDA to discuss their protocols to get a sense of whether the FDA will approve the drug pending a successful outcome with regard to safety and efficacy. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063